Eben Rosenthal named medical director of Stanford Cancer Center

Eben Rosenthal, MD, an otolaryngologist, cancer researcher and professor of surgery at the University of Alabama at Birmingham, has been named the next associate director of clinical care of the Stanford Cancer Institute and medical director of the Stanford Cancer Center.

Effective July 1, Rosenthal will coordinate the activities of all School of Medicine departments and services involved in cancer care, both ambulatory and inpatient.

“Eben’s leadership in clinical care, and in the lab and classroom, will serve the Stanford Cancer Institute well as it strives to transform the cancer patient’s experience by incorporating clinical and translational science and creating a new standard of care,” said Lloyd Minor, MD, dean of the School of Medicine. “We are confident in his ability to lead the Cancer Center forward to preeminence.”

At UAB — one of the five largest academic medical centers in the country — Rosenthal served as director of the Division for Otolaryngology-Head and Neck Surgery, and led its oncology research group, playing a key role in advancing treatment for head and neck cancers at the university’s medical center. His research and clinical interests include head and neck oncology and microvascular reconstruction, targeted cancer therapies and novel surgical imaging technologies.

“With his experience in translational research, clinical care and organizational leadership, Eben is a tremendous asset to our effort to redefine the care experience for every cancer patient at Stanford,” said Beverly Mitchell, MD, director of the Stanford Cancer Institute.

Rosenthal will arrive on campus during the early stages of the Stanford Cancer Initiative, a five-year, multifaceted effort to advance the delivery and efficacy of cancer care. The initiative is a joint effort of the Stanford Cancer Institute and Stanford Heath Care that combines research, technology and compassion to deliver comprehensive, patient-focused care.

“Being selected for this position at this time of incredible growth and commitment of institutional resources is an honor,” Rosenthal said. “I look forward to working with the very talented physicians and their teams to deliver the highest possible quality of cancer care.”

Rosenthal is board certified in otolaryngology and in facial plastic and reconstructive surgery. He earned a medical degree and conducted his residency program in otolaryngology at the University of Michigan.

In a joint statement, Minor and Mitchell acknowledged the cooperative recruiting efforts of Amir Dan Rubin, president and CEO of Stanford Health Care; Sridhar Seshadri, vice president of cancer services at Stanford Cancer Institute; and James Hereford, chief operating officer at Stanford Health Care.